CLOTRIMAZOLE USP1%

CLOTRIMAZOLE USP1% was reported 38 times

CLOTRIMAZOLE USP1% is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SCROTAL HAEMATOCOELE 1 0.0120
1 BLOOD VISCOSITY ABNORMAL 1 0.0105
2 KYPHOSCOLIOSIS 1 0.0038
3 BLOOD VISCOSITY DECREASED 1 0.0030
4 TINEA CRURIS 1 0.0020
5 NAIL BED BLEEDING 1 0.0018
6 BLOOD IMMUNOGLOBULIN M INCREASED 1 0.0016
7 PNEUMOCOCCAL SEPSIS 1 0.0015
8 ORTHOSTATIC INTOLERANCE 1 0.0014
9 PENILE HAEMORRHAGE 1 0.0012
10 DRUG DISPENSED TO WRONG PATIENT 1 0.0010
11 ONYCHALGIA 1 0.0010
12 LEFT ATRIAL DILATATION 1 0.0008
13 PRODUCT EXPIRATION DATE ISSUE 1 0.0007
14 CATAPLEXY 1 0.0007
15 INVESTIGATION ABNORMAL 1 0.0007
16 PNEUMONIA PNEUMOCOCCAL 1 0.0007
17 TOTAL LUNG CAPACITY DECREASED 1 0.0006
18 LAZINESS 1 0.0006
19 PRODUCT LOT NUMBER ISSUE 1 0.0005
20 FLAT AFFECT 1 0.0004
21 STARING 1 0.0004
22 PRODUCT PACKAGING CONFUSION 1 0.0004
23 APPLICATION SITE HAEMORRHAGE 1 0.0004
24 WOUND SECRETION 1 0.0003
25 PARONYCHIA 1 0.0002
26 FEELING OF DESPAIR 1 0.0002
27 MEDICATION RESIDUE PRESENT 1 0.0002
28 SCOLIOSIS 1 0.0002
29 ATRIAL FLUTTER 1 0.0001
30 VITAMIN D DECREASED 1 0.0001
31 VAGINAL DISCHARGE 1 0.0001
32 INITIAL INSOMNIA 1 0.0001
33 TENDERNESS 1 0.0001
34 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
35 ASPIRATION 1 0.0001
36 APPLICATION SITE PAIN 2 0.0001
37 ATAXIA 1 0.0001
38 MUSCLE SPASTICITY 1 0.0001
39 ABASIA 2 0.0001
40 TOOTH INFECTION 1 0.0001
41 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
42 APHONIA 1 0.0001
43 SINUS TACHYCARDIA 1 0.0001
44 ULCER 1 0.0001
45 OBESITY 1 0.0001
46 ABSCESS 1 0.0001
47 FOOT FRACTURE 1 0.0001
48 SLEEP APNOEA SYNDROME 1 0.0001
49 APPLICATION SITE PRURITUS 1 0.0000
50 CEREBRAL INFARCTION 1 0.0000
51 ENCEPHALOPATHY 1 0.0000
52 AGEUSIA 1 0.0000
53 DEAFNESS 1 0.0000
54 MENTAL STATUS CHANGES 1 0.0000
55 RED BLOOD CELL COUNT DECREASED 1 0.0000
56 HYPERSOMNIA 1 0.0000
57 STOMATITIS 2 0.0000
58 EPILEPSY 1 0.0000
59 DRUG-INDUCED LIVER INJURY 1 0.0000
60 HEAD INJURY 1 0.0000
61 SKIN DISORDER 1 0.0000
62 URINARY RETENTION 1 0.0000
63 DRUG EFFECT INCOMPLETE 1 0.0000
64 HYPERGLYCAEMIA 1 0.0000
65 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
66 DISORIENTATION 1 0.0000
67 POLLAKIURIA 1 0.0000
68 ADVERSE DRUG REACTION 2 0.0000
69 RASH ERYTHEMATOUS 1 0.0000
70 CELLULITIS 1 0.0000
71 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
72 TREATMENT NONCOMPLIANCE 1 0.0000
73 HYPONATRAEMIA 1 0.0000
74 DISCOMFORT 1 0.0000
75 FEBRILE NEUTROPENIA 1 0.0000
76 HEPATIC ENZYME INCREASED 1 0.0000
77 INJURY 1 0.0000
78 SLEEP DISORDER 1 0.0000
79 UNDERDOSE 1 0.0000
80 ACNE 1 0.0000
81 BLOOD PRESSURE INCREASED 2 0.0000
82 THROMBOSIS 1 0.0000
83 BALANCE DISORDER 1 0.0000
84 SWELLING 1 0.0000
85 PRODUCT USE ISSUE 2 0.0000
86 CONTUSION 1 0.0000
87 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
88 BACK PAIN 2 0.0000
89 DISEASE PROGRESSION 1 0.0000
90 LOSS OF CONSCIOUSNESS 1 0.0000
91 HYPERHIDROSIS 1 0.0000
92 DRY SKIN 1 0.0000
93 PRODUCT QUALITY ISSUE 1 0.0000
94 COUGH 2 0.0000
95 CONDITION AGGRAVATED 2 0.0000
96 PNEUMONIA 2 0.0000
97 CEREBROVASCULAR ACCIDENT 1 0.0000
98 MYALGIA 1 0.0000
99 URINARY TRACT INFECTION 1 0.0000
100 MYOCARDIAL INFARCTION 1 0.0000
101 HYPERSENSITIVITY 1 0.0000
102 ASTHENIA 2 0.0000
103 BLOOD GLUCOSE INCREASED 1 0.0000
104 GAIT DISTURBANCE 1 0.0000
105 ALOPECIA 1 0.0000
106 ERYTHEMA 1 0.0000
107 DRUG INEFFECTIVE 6 0.0000
108 WEIGHT INCREASED 1 0.0000
109 DECREASED APPETITE 1 0.0000
110 FATIGUE 3 0.0000
111 PRODUCT DOSE OMISSION ISSUE 1 0.0000
112 HEADACHE 2 0.0000
113 FALL 1 0.0000
114 PRURITUS 1 0.0000
115 RASH 1 0.0000
116 DIZZINESS 1 0.0000
117 PAIN 1 0.0000
118 DIARRHOEA 1 0.0000
119 NAUSEA 1 0.0000